Spermine modulation of the glutamateNMDA receptor is differentially responsive to conantokins in normal and Alzheimer's disease human cerebral cortex

Journal of Neurochemistry

Volumn 81, Issue 4, 2002, Pages 765-779

  Ragnarsson, Lotten ^a   Mortensen, Martin ^a,b   Dodd, Peter R ^a   Lewis, Richard J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Conantokin peptides; Excitotoxicity; Glutamate; MK 801; Pathogenesis; Polyamines

Indexed keywords

ALANINE; CONANTOKIN G; DIZOCILPINE; GLUTAMATE RECEPTOR; LYSINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBUNIT; SPERMINE;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BINDING AFFINITY; BINDING SITE; BRAIN CORTEX; BRAIN REGION; BRAIN TISSUE; CONTROLLED STUDY; DRUG BINDING; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RECEPTOR DENSITY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; BINDING, COMPETITIVE; CEREBRAL CORTEX; CONOTOXINS; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GLUTAMIC ACID; HUMANS; LIGANDS; MALE; MIDDLE AGED; MUTAGENESIS, SITE-DIRECTED; RADIOLIGAND ASSAY; RECEPTORS, N-METHYL-D-ASPARTATE; SPERMINE;

EID: 0036312870     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.00872.x     Document Type: Article

References (60)

1. Alternative excitotoxic hypotheses
2. Relationship between N-methyl-D-aspartate receptor NR1 splice variants and NR2 subunits
3. Ligands for glutamate receptors: Design and therapeutic prospects
4. Radioligand-receptor binding studies: What's wrong with Scatchard analysis?
5. Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type
6. Polyamine-like actions of peptides derived from conantokin-G, an N-methyl-D-aspartate (NMDA) antagonist
7. Excitotoxic cell death
8. Presynaptic and post-synaptic glutamatergic function in Alzheimer's disease
9. The glutamate receptor ion channels
10. Glutamate-mediated transmission, alcohol, and alcoholism
11. Optimization of freezing, storage, and thawing conditions for the preparation of metabolically active synaptosomes from frozen rat and human brain
12. Excitotoxic mechanisms in the pathogenesis of dementia
13. Conantokin G is an NR2B-selective competitive antagonist of N-methyl-D-aspartate receptors
14. Splice variants of the N-methyl-D-aspartate receptor NR1 identify domains involved in regulation by polyamines and protein kinase C
15. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain
16. Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease
17. Excitatory amino acids and Alzheimer's disease
18. 3H]glutamate binding
19. Alzheimer's disease: Cell-specific pathology isolates the hippocampal formation
20. GlutamateNMDA receptor NR1 subunit mRNA expression in Alzheimer's disease
21. Antagonist properties of polyamines and bis (ethyl) polyamines at N-methyl-D-aspartate receptors
22. Modulation of channel function by polyamines
23. 3H]MK-801 binding in immature and mature chicken forebrain
24. Diagnosis of Alzheimer's disease
25. Evidence for a tetrameric structure of recombinant NMDA receptors
26. Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition
27. The glycine site on the NMDA receptor: Structure activity relationships and therapeutic potential
28. Secrets of the cone shells
29. Protein measurement with the Folin phenol reagent
30. Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes
31. A practical computer-based approach to the analysis of radioligand binding experiments
32. 3H]TCP binding in Alzheimer's disease
33. Excitatory amino acid neurotoxicity and neurodegenerative disease
34. The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system
35. Brain polyamine levels are altered in Alzheimer's disease
36. The modulatory effect of spermine on the glutamate-NMDA receptor is regionally variable in normal human adult cerebral cortex
37. LIGAND: A versatile computerized approach for characterization of ligand-binding systems
38. Conus peptides as chemical probes for receptors and ion channels
39. Structure-activity relationships of conantokins at the human glutamate-NMDA receptor
40. Diversity of Conus neuropeptides
41. Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate
42. Calcium binding properties of synthetic γ-carboxyglutamic acid-containing marine Cone snail 'sleeper' peptides, conantokin-G and conantokin-T
43. Characterization of the effects of polyamines on the modulation of the N-methyl-D-aspartate receptor by glycine
44. Polyamine regulation of N-methyl-D-aspartate receptor channels
45. Glutamate and the pathophysiology of hypoxicischemic brain damage
46. Exon 5 and spermine regulate deactivation of NMDA receptor subtypes
47. Characterization of the effects of polyamines on [125I]MK-801 binding to recombinant N-methyl-D-aspartate receptors
48. Non-competitive inhibition of N-methyl-D-aspartate by conantokin-G: Evidence for an allosteric interaction at polyamine sites
49. 3H]MK-801 binding to the NMDA receptor complex in human cortical membranes
50. Polyamine effects on the NMDA receptor in human brain
51. Genetic enhancement of learning and memory in mice
52. Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles
53. Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines
54. Decreased expression of N-methyl-D-aspartate receptor 1 messenger RNA in select regions of Alzheimer brain
55. Interactions of polyamines with ion channels
56. Modulation of the NMDA receptor by polyamines
57. Synthetic analogues of conantokin-G: NMDA antagonists acting through a novel polyamine-coupled site